event-trade登录编辑
🇺🇸 SECFold Holdings, Inc.Codex · 实盘不做把握 5/10不做原因:风险收益比不佳
北京时间·🕒 发布 05:00:14·⟳ 抓取 14:14:57 +9h14m·⚡ 决策 09-03 14:39:21 +24m24s·54.3 天前

Fold Holdings终止2.5亿美元股权购买融资安排并设定特别股东会议日期

该8-K是公司一手披露,但核心增量是终止备用股权融资安排并保留替代融资选项;它更像融资路径调整而非确定的每股权益改善或经营催化,短线做多/做空的正期望不足。

📄 原文Fold Holdings, Inc.↗ 原文
----- fld-20260827.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT R…
不做 Fold Holdings, Inc.(FLD.US)
融资工具终止与替代融资选项并存,净稀释和每股价值影响未定;特别股东会议日期偏程序性,缺少足够短线edge。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

结论摘要

原融资安排最高可发行2.5亿美元新股,终止本身降低既有稀释工具的可用性;但公司明确称目的是保留替代融资选项,未披露新融资条款、规模、成本或是否更有利于现有股东。特别股东会议日期也是此前委托书事项的程序推进,不构成独立强催化。因此回避Fold Holdings(FLD.US)。

🔎 新鲜度:最早出现 2026-09-02 · 扩散 low · price-in 风险 medium ↗

关键理由

  • 终止最高2.5亿美元股权购买安排可边际降低原有按需发股稀释通道。
  • 截至通知日没有未履行的Advance Notices,终止不伴随罚金,避免了立即新增发行义务。

主要风险

  • 公司称终止是为替代融资保留选项,后续融资可能仍有稀释或更高资本成本。
  • 特别股东会议事项并非本披露首次完整说明,程序性日期本身缺乏可量化价值增量。

反向证据

  • 做多前查反向 · 来源 filing · 日期 2026-09-02 · 影响 weakens
    披露文件自身给出关键反证:终止原因是保留替代融资选项,未说明替代融资更少稀释或成本更低。
    检索:Fold Holdings 终止 equity purchase facility 替代融资 稀释 原文 ↗
  • 做空前查反向 · 来源 filing · 日期 2026-09-02 · 影响 weakens
    公司披露没有未履行Advance Notices且无终止罚金,事件不足以构成明确强空催化。
    检索:Fold Holdings 终止 equity purchase facility Advance Notices penalty 原文 ↗

先例如何影响了这次决策

对本次决策的影响:先例证据不足使该融资路径调整事件只能按当前披露本身判断,降低交易置信和仓位至不做。

方向:未取得可对齐的同市场同机制先例,不能用历史反应支撑交易方向。

涨幅量级:缺少高相似先例,无法校准短线涨跌幅。

形态:未形成可复用的见光死或延续上涨样本。

原文全文

展开原文 · 7,029 字
----- fld-20260827.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 27, 2026
Fold Holdings, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-41168
86-2170416
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
2942 North 24th Street
,
Suite 115
,
#42035
Phoenix
,
Arizona
85016
(Address of principal executive offices)
(Zip Code)
(
866
)
365-3277
Registrant’s telephone number, including area code
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange on Which
Registered
Common stock, par value $0.0001 per share
FLD
Nasdaq
Capital Market
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share
FLDDW
Nasdaq
Capital Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
ITEM 1.02 TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.
On August 27, 2026, Fold Holdings, Inc. (the "Company") delivered written notice to the investor (the "Investor") party to the Equity Purchase Facility Agreement, dated as of June 16, 2025 (the "Facility"), by and between the Company and the Investor, notifying the Investor of the Company's election to terminate the Facility. In accordance with the termination provisions of the Facility, the termination will become effective on September 3, 2026. As of the date of such notice, there were no outstanding Advance Notices (as defined in the Facility) under which the Company was obligated to issue shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), to the Investor.
As previously disclosed in the Company’s Current Report on Form 8-K filed June 17, 2025, pursuant to the Facility, the Investor had committed to purchase, subject to certain conditions and limitations, up to $250,000,000 in newly issued shares of Common Stock (the "Commitment"), which the Company had the right, but not the obligation, to draw upon from time to time in its sole discretion by delivering advance notices to the Investor. The purchase price per share for shares sold to the Investor under the Facility was calculated upon the terms described therein. In connection with entering into the Facility, the Company and the Investor also entered into a Registration Rights Agreement, dated as of June 16, 2025 (the "Registration Rights Agreement"), pursuant to which the Company agreed to file with the Securities and Exchange Commission a registration statement registering the resale by the Investor of the shares of Common Stock issuable under the Facility.
The Company terminated the Facility in order to provide the Company with the option of alternative financing. The Company did not incur any prepayment fees or penalties as a result of terminating the Facility. Upon the termination of the Facility becoming effective, the Company's obligations under the Registration Rights Agreement will also terminate in accordance with the terms thereof, except to the extent the Investor then holds any Registrable Securities (as defined in the Registration Rights Agreement), in which case the Company's obligations under the Registration Rights Agreement with respect to such Registrable Securities will survive such termination.
The foregoing description of the Facility and the Registration Rights Agreement is qualified in its entirety by reference to the full text of such agreements, copies of which are incorporated herein by reference as Exhibit 10.1 and Exhibit 10.2, respectively.
ITEM 7.01 REGULATION FD DISCLOSURE.
The Company hereby announces that its Board of Directors has set October 22, 2026 as the date of a special shareholder meeting concerning the matters previously disclosed in the preliminary proxy statement filed by the Company on August 7, 2026. The record date for such meeting will be September 4, 2026.
The information contained in Item 7.01 of this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly provided by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit No.
Description
10.1*^
Equity Purchase Facility Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.1 to that Current Report on Form 8-K filed by the Company on June 17, 2025).
10.2*^
Registration Rights Agreement, dated as of June 16, 2025, by and between the Company and the Investor (incorporated by reference to Exhibit 10.2 to that Current Report on Form 8-K filed by the Company on June 17, 2025).
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
* Certain schedules, exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of such schedules, or any section thereof, to the SEC upon request.
^ Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The registrant agrees to furnish supplementally an unredacted copy of the exhibit to the Securities and Exchange Commission upon its request.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
FOLD HOLDINGS, INC.
By:
/s/ Will Reeves
Name:
Will Reeves
Title:
Chief Executive Officer
Dated: September 2, 2026

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。